T-ALL with TEL/AML1 Translocation, Aberrant Expression of CD19 and 33: Case Report and Literature Review
Open Access
- 14 December 2016
- journal article
- Published by Peertechz Publications Private Limited
- Vol. 1 (1), 001-004
- https://doi.org/10.17352/abmr.000001
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Peripheral T-Cell Lymphoma with Aberrant Expression of CD19, CD20, and CD79a: Case Report and Literature ReviewCase Reports in Hematology, 2013
- Novel CD19 expression in a peripheral T cell lymphoma: A flow cytometry case report with morphologic correlationCytometry Part B: Clinical Cytometry, 2008
- Aberrant myeloid marker expression in precursor B-cell and T-cell leukemiasExperimental and Molecular Pathology, 2007
- Cytogenetic patterns in ETV6/RUNX1‐positive pediatric B‐cell precursor acute lymphoblastic leukemia: A Nordic series of 245 cases and review of the literatureGenes, Chromosomes and Cancer, 2007
- Genetic abnormalities associated with the t(12;21) and their impact in the outcome of 56 patients with B-precursor acute lymphoblastic leukemiaCancer Genetics and Cytogenetics, 2005
- Mechanism, detection and clinical significance of the reciprocal translocation t(12;21)(p12;q22) in the children suffering from acute lymphoblastic leukaemiaLeukemia Research, 2004
- Pediatric Acute Lymphoblastic LeukemiaHematology, 2003
- Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working partyLeukemia, 2002
- Peripheral T-Cell Lymphoma with Aberrant Expression of CD79a and CD20: A Diagnostic PitfallLaboratory Investigation, 2001
- TEL‐AML1 fusion in acute lymphoblastic leukaemia of adultsBritish Journal of Haematology, 1996